Login / Signup

Efficacy and safety of rituximab in autoimmune encephalitis: A meta-analysis.

Gaurav NepalYow K ShingJayant K YadavJessica H RehrigRajeev OjhaDong Y HuangBikram P Gajurel
Published in: Acta neurologica Scandinavica (2020)
Our meta-analysis showed that rituximab is an effective second-line agent for AE with an acceptable toxicity profile.
Keyphrases
  • diffuse large b cell lymphoma
  • systematic review
  • chronic lymphocytic leukemia
  • hodgkin lymphoma
  • meta analyses
  • multiple sclerosis
  • oxidative stress
  • case control
  • randomized controlled trial
  • drug induced